Soleno Therapeutics (SLNO) Inventory Average (2015 - 2026)
Soleno Therapeutics (SLNO) reported Inventory Average of $16.2 million for Q1 2026, up 49.01% quarter-over-quarter from $10.8 million in Q4 2025.
Soleno Therapeutics (SLNO) Inventory Average (2015 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 5 years of Inventory Average data on file, last reported at $16.2 million in Q1 2026.
- Inventory Average for Q1 2026 came in at $16.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $16.2 million (changed N/A YoY), and the FY2015 annual result was $330172.0, changed N/A from the prior year.
- Inventory Average climbed to $16.2 million in Q1 2026 per SLNO's latest filing, from $10.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $16.2 million in Q1 2026 and troughed at $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 16.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.17 Mn |
| Dec 31, 2025 | 10.85 Mn |
| Sep 30, 2025 | 4.51 Mn |
| Jun 30, 2017 | 509,500.00 |
| Sep 30, 2016 | 738,500.00 |
| Jun 30, 2016 | 713,500.00 |
| Mar 31, 2016 | 602,004.00 |
| Dec 31, 2015 | 463,504.00 |
| Sep 30, 2015 | 326,500.00 |
| Jun 30, 2015 | 241,500.00 |
| Mar 31, 2015 | 157,668.00 |